Pfizer gaining market share in oncology: CEO
0
Pfizer's share of the market for certain cancer drugs has increased from 10 to 20 percent, CEO Ian Read tells CNBC.
Pfizer's share of the market for certain cancer drugs has increased from 10 to 20 percent, CEO Ian Read tells CNBC.